With reference to the SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015 (Listing Regulations), Neelamalai Agro Industries has informed that, as required in terms of Regulations 30, 33 and other applicable provisions of Listing Regulations, the Board of Directors of the company at its meeting held today 13th February, 2026, which commenced at 11:55 AM and concluded at 12.50 PM has transacted the following business: The Un-audited Financial Results (Standalone & Consolidated) for the Third quarter and Nine months ended December 31, 2025, along with Limited Review Report issued by PKF Sridhar & Santhanam LLP, Chartered Accountants, and Statutory Auditors of the Company. Pursuant to Regulation 30 read with Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ('Listing Regulations'), the Board of Directors of the Company, at their meeting held today, Friday, February 13, 2026, based on the recommendation of the Nomination and Remuneration Committee, and subject to the approval of the shareholders of the Company through Postal Ballot process, by way of Special Resolution approved Re-appointment of S. Ganesan (DIN: 08588380) as Non- Executive Independent Director for a second term of 5 years, i.e., from 01.07.2026 to 30.06.2031 S. Ganesan (DIN: 08588380) has confirmed that he meets the criteria of ‘independence’ under Section 149 of the Companies Act, 2013, and Regulation 16 of the Listing Regulations. Further, he has also confirmed that he has not been debarred from holding the office of Director by virtue of any Order passed by the Securities and Exchange Board of India or any other such authority. The disclosures required under Regulation 30 of the Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/PICIR/2023/123 dated July 13, 2023, concerning the above reappointments, are enclosed as Annexure I to this letter. The meeting commenced at 11.55 AM and concluded at 12.50 PM.

The above information is a part of company’s filings submitted to BSE.